Revance Therapeutics Inc (RVNC)
3.57
-0.09
(-2.46%)
USD |
NASDAQ |
Apr 24, 16:00
3.575
0.00 (0.00%)
After-Hours: 20:00
Revance Therapeutics Total Assets (Quarterly): 478.45M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 478.45M |
| September 30, 2023 | 532.49M |
| June 30, 2023 | 597.54M |
| March 31, 2023 | 547.80M |
| December 31, 2022 | 581.90M |
| September 30, 2022 | 711.59M |
| June 30, 2022 | 561.88M |
| March 31, 2022 | 639.55M |
| December 31, 2021 | 531.16M |
| September 30, 2021 | 581.83M |
| June 30, 2021 | 640.88M |
| March 31, 2021 | 675.95M |
| December 31, 2020 | 720.22M |
| September 30, 2020 | 712.15M |
| June 30, 2020 | 576.18M |
| March 31, 2020 | 592.93M |
| December 31, 2019 | 340.29M |
| September 30, 2019 | 265.81M |
| June 30, 2019 | 295.89M |
| March 31, 2019 | 324.48M |
| December 31, 2018 | 226.35M |
| September 30, 2018 | 233.05M |
| Date | Value |
|---|---|
| June 30, 2018 | 259.12M |
| March 31, 2018 | 284.78M |
| December 31, 2017 | 295.70M |
| September 30, 2017 | 169.18M |
| June 30, 2017 | 187.08M |
| March 31, 2017 | 209.45M |
| December 31, 2016 | 204.36M |
| September 30, 2016 | 226.86M |
| June 30, 2016 | 237.01M |
| March 31, 2016 | 259.00M |
| December 31, 2015 | 275.82M |
| September 30, 2015 | 165.51M |
| June 30, 2015 | 171.22M |
| March 31, 2015 | 175.72M |
| December 31, 2014 | 192.47M |
| September 30, 2014 | 208.92M |
| June 30, 2014 | 223.32M |
| March 31, 2014 | 106.91M |
| December 31, 2013 | 22.64M |
| September 30, 2013 | 18.92M |
| December 31, 2012 | 13.42M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
265.81M
Minimum
Sep 2019
720.22M
Maximum
Dec 2020
557.08M
Average
581.83M
Median
Sep 2021
Total Assets (Quarterly) Benchmarks
| AbbVie Inc | 134.71B |
| Alnylam Pharmaceuticals Inc | 3.830B |
| Ionis Pharmaceuticals Inc | 2.990B |
| Madrigal Pharmaceuticals Inc | 640.55M |
| Vertex Pharmaceuticals Inc | 22.73B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 630.06M |
| Shareholders Equity (Quarterly) | -151.60M |
| Debt to Equity Ratio | -2.830 |
| Current Ratio | 3.798 |
| Net Debt Paydown Yield | -1.30% |